INDICATIONS AND USAGE Asthma: SEREVENT DISKUS is indicated for long-term, twice-daily (morning and evening) administration in the maintenance treatment of asthma and in the prevention of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease, including patients with symptoms of nocturnal asthma, who require regular treatment with inhaled, short-acting beta2-agonists. It is not indicated for patients whose asthma can be managed by occasional use of inhaled, short-acting beta2-agonists. SEREVENT DISKUS is also indicated for prevention of exercise-induced bronchospasm in patients 4 years of age and older. SEREVENT DISKUS may be used alone or in combination with inhaled or systemic corticosteroid therapy. Chronic Obstructive Pulmonary Disease: SEREVENT DISKUS is indicated for the long-term, twice-daily (morning and evening) administration in the maintenance treatment of bronchospasm associated with COPD (including emphysema and chronic bronchitis). DOSAGE AND ADMINISTRATION SEREVENT DISKUS should be administered by the orally inhaled route only (see Patient's Instructions for Use). The patient must not exhale into the DISKUS and the DISKUS should only be activated and used in a level, horizontal position. Asthma: For maintenance of bronchodilatation and prevention of symptoms of asthma, including the symptoms of nocturnal asthma, the usual dosage for adults and children 4 years of age and older is 1 inhalation (50 mcg) twice daily (morning and evening, approximately 12 hours apart). | ||||
Email this article
Printer friendly
Bookmark this pageadvertisement
